Hiro Tatetsu

8PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Taichi Hirano, Hiro Tatetsu, Shikiko Ueno

|Oct 23, 2025
Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.

Takafumi Shichijo, Hiro Tatetsu, Yusuke Higuchi

|Oct 21, 2025
Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy.

Hiro Tatetsu, Koji Kato, Atsushi Wada

|Sep 25, 2024
Decreased PU.1 expression in mature B cells induces lymphomagenesis.

Shinya Endo, Nao Nishimura, Kosuke Toyoda

|Jun 30, 2023
Robust prognostic value of histologic transformation in patients with early progression of follicular lymphoma.

Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka

|Jun 28, 2023
Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma.

Hiro Tatetsu, Yusuke Higuchi, Takafumi Shichijo

Pageof 2